UiPath, Inc. (PATH) stock
PATHNYSEServices-Prepackaged SoftwareFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 8, 2026Score 14/304% above fair value
$13.14+0.31 (+2.42%)
Close on Nov 11, 2026Market cap $6.85BP/E 19.6Yield –
UiPath r&d expenses
Research and development expenses are spending on new products and technology.
UiPath's R&D Expenses for the twelve months ending Jul 31, 2026 was $368.32M, down 5.5% year over year. For fiscal 2026 it was $385.21M, up 1.2% from the year before. The highest annual figure on record is $385.21M in fiscal 2026.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $385.21M | +1.2% |
| FY2025 | Jan 31, 2025 | $380.68M | +14.6% |
| FY2024 | Jan 31, 2024 | $332.10M | +16.2% |
| FY2023 | Jan 31, 2023 | $285.75M | +3.3% |
| FY2022 | Jan 31, 2022 | $276.66M | +151.7% |
| FY2021 | Jan 31, 2021 | $109.92M | -16.1% |
| FY2020 | Jan 31, 2020 | $131.07M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | $83.39M | -15.2% |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | $92.90M | -2.0% |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | $95.16M | -4.5% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | $96.87M | -0.1% |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | $98.34M | -0.1% |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | $94.84M | +10.8% |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | $99.67M | +16.4% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | $96.98M | +14.7% |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | $98.43M | +13.7% |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | $85.60M | +13.6% |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $85.64M | +4.6% |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $84.51M | +25.5% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $86.61M | +27.6% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $75.34M | +9.7% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $81.87M | +27.1% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $67.34M | +9.4% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $67.85M | +17.7% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $68.69M | -26.2% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $64.41M | +120.6% |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $61.56M | +124.2% |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | $57.65M | +117.2% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $93.04M | +248.1% |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $29.19M | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $27.46M | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $26.54M | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | $26.73M | – |
See a number that looks wrong?